Sero-type | EOD (N = 155) | LOD (N = 51) | Maternal (N = 19) | Stillbirth (N = 4) | Total GBS Invasive Isolates (N = 229) | Swedish GBS Commensal Isolates (N = 356) | p-value, total invasive vs. commensal |
---|---|---|---|---|---|---|---|
Ia | 30 (19.4%) | 4 (7.8%) | 1 (5.3%) | 1 (25%) | 36 (15.7%) | 39 (11%) | 0.1 |
Ib | 8 (5.2%) | 1 (2.0%) | 5 (26.3%) | 14 (6.1%) | 46 (13%) | 0.008 | |
II | 8 (5.2%) | 1 (2.0%) | 1 (5.3%) | 1 (25%) | 11 (4.8%) | 57 (16%) | < 0.001 |
III | 78 (50.3%) | 36 (70.6%) | 3 (15.8%) | 117 (51.1%) | 85 (24%) | < 0.001 | |
IV | 3 (1.9%) | 2 (3.9%) | 2 (10.5%) | 7 (3.1%) | 53 (15%) | < 0.001 | |
V | 25 (16.1%) | 5 (9.8%) | 7 (36.8%) | 2 (50%) | 39 (17.0%) | 68 (19%) | 0.58 |
VII | 1 (0.6%) | 1 (0.4%) | 2 (0.5%) | 1 | |||
VIII | 1 (2.0%) | 1 (0.4%) | 4 (1%) | 0.65 | |||
IX | 1 (0.6%) | 1 (2.0%) | 2 (0.9%) | 0 (0%) | 0.15 | ||
NT | 1 (0.6%) | 1 (0.4%) | 2 (0.8%) |